Table 1.
Different vaccine strategies available for Nipah virus (NiV).
Vector | Antigen used | Dose for immunization | Animal model | Route of vaccination | Administration frequency | Challenge with virus titer | Route of challenge | References |
---|---|---|---|---|---|---|---|---|
Vesicular stomatitis virus (VSV) | rVSV expressing NiV G | 105 plaque forming units (PFU) | Hamsters | Intraperitoneal | Single | 6.8 × 104 TCID50 (1000 LD50) | Intraperitoneal | DeBuysscher et al. 2014 |
rVSV-ZEBOV-GP-NiVG | 107 PFU | African Green monkey | intramuscular | Single | 105 TCID50 (Malaysian strain) | Intratracheal | Prescott et al. 2015 | |
rVSV-ΔG-NiVB/G | 107 PFU | Ferrets | Intramuscular | Single | ∼5 × 105 PFU | Equally divided between intratracheal and intranasal routes | Mire et al. 2013 | |
Replication-defective VSV | 106 infectious particles | Female Syrian golden hamsters | Intramuscular | Single | 105 TCID50 per hamster (>1000 times LD50- Malaysian strain) | Intraperitoneal | Lo et al. 2014 | |
Canarypox virus (ALVAC) vaccine vector | vCP2199, carrying the NiV-G and vCP2208, carrying the NiV F | 108 PFU | Landrace female pigs | Intramuscular | Boosted 14 days postvaccination | 2.5 × 105 PFU | Intranasal challenge | Weingartl et al. 2006 |
Adeno-associated virus (AAV) | NiV G | 2.1010/1.1010 genome particles | Balb/c male mice | Intra muscular or intra-dermal | One Booster | 104 PFU | Intraperitoneal | Ploquin et al. 2013 |
6.1011 genome particles | Golden hamsters | Intra muscular | ||||||
Vaccinia virus | NiV G and NiV F | 107 PFU | BALB/c female mice | Subcutaneously | Boosted with the same dose | 1,000 PFU | Intraperitoneal | Guillaume et al. 2004b |
Measles virus based-vectors (HL strain or Edmonston B strain) | NiV G | 1 × 105 TCID50 | African green monkeys | Subcutaneously | One booster | 1 × 106 TCID50 | Intraperitoneal | Yoneda et al. 2013 |
2 × 104 TCID50 | Hamsters | Intraperitoneal | 1 × 108 TCID50 | Intranasal | ||||
Venezuelan equine encephalitis virus replicon particles | NiV G | 3.1 × 105 IU | C3H/He mice | Foot pad inoculation | Single | Serum neutralization assay with pNL4-3.luc.E-R-reporter-gene encoding retroviruses pseudo-typed with NiV F + NiV G glycoproteins | – | Defang et al. 2010 |
Newcastle disease virus (NDV), LaSota strains | NiVG and NiVF | 108 EID50 | Mice | Intramuscular | Single | Serum neutralization assay with VSVDGnGFP-NiV G/F pseudo- typed virus | – | Kong et al. 2012 |
2 × 109 EID50 | Pig | Intramuscular | ||||||
Nipah virus-like particles (NiV-VLPs) | NiV G, F and M adjuvanted with Alum (50 µg -Alhydrogel 2%); MPLA (15 µg) and CpG ODN (40 µg) | 30 µg VLP | Golden Syrian hamsters | Intramuscular | Three-dose vaccination schedule | ∼16,000 PFU | Intraperitoneal | Walpita et al. 2017 |